The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers to use rebates rather than upfront discounts to effectuate the 340B ceiling price for certain drugs purchased by 340B covered entities.
340B Advocacy Alliance Bulletin
The U.S. District Court for the District of Columbia today upheld a lower court’s decision that Section 340B of the Public Health Service Act does not permit drug companies to impose proposed rebate models on 340B purchasers unless the Secretary of the Department of Health and Human Services…
AHA 340B Advocacy Alliance Bulletin: AHA Urges HRSA to Revise 340B Rebate Program Workload Estimates
The AHA today urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s proposed 340B rebate model pilot program, saying the agency’s projection of five hours of work per week significantly understates the real-world…
AHA 340B Advocacy Alliance Bulletin: AHA Urges HRSA to Revise 340B Rebate Program Workload Estimates
The AHA today urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s proposed 340B rebate model pilot program, saying the agency’s projection of five hours of work per week significantly understates the real-world…
The AHA today released legislative advisories on a 340B bill introduced by a bipartisan House working group and a legislative discussion draft introduced in the Senate.
If you haven’t done so yet, please register for an AHA 340B Advocacy Alliance call on July 8 at 3 p.m. ET to hear the latest updates on the 340B Drug Pricing Program.
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.4% in calendar year 2027 compared to CY 2026.
Join the AHA 340B Advocacy Alliance on July 8 at 3 p.m. ET for the latest updates on the 340B Drug Pricing Program and opportunities to engage directly with AHA 340B team members.
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a legislative discussion draft that would make several changes to the 340B Drug Pricing Program.
HRSA seeks input on 340B Rebate Model.